MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Anatomical Substrates for Motor Subcomponents of Bradykinesia in Parkinson’s Disease after Subthalamic Nucleus Deep Brain Simulation

    MJ. Kim, Y. Shi, Y. Salimpour, WS. Anderson, K. Mills (Baltimore, USA)

    Objective: To evaluate distinct anatomical substrates modulating motor subcomponents of bradykinesia following Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD). Background: PD…
  • 2022 International Congress

    Deep Brain Stimulation in Generalized Dystonia Caused by PRKRA Mutation

    A. Falcone, C. Listik, S. Barbosa Casagrande, M. Torres, D. Boari Coelho, L. Augusto Teixeira, J. Papaterra Limongi, M. Jacobsen Teixeira, E. Reis Barbosa, R. Cury (Caçapava, Brazil)

    Objective: Dystonia is a hyperkinetic movement disorder with a complex pathophysiology. The medical treatment includes pharmacological treatment, including botulinum toxin (BoNT), which is considered the…
  • 2022 International Congress

    Evaluation of the association between total electrical energy delivered (TEED) and cognitive function six months after DBS in patients with Parkinson’s disease

    F. Ruggiero, F. Mameli, M. Dini, S. Marceglia, M. Prenassi, L. Borellini, F. Cogiamanian, E. Pirola, E. Zirone, D. Mellace, B. Capetti, L. Remore, G. Fiore, MR. Reitano, N. Maiorana, M. Locatelli, S. Barbieri, A. Priori, R. Ferrucci (Milan, Italy)

    Objective: We aimed to investigate the neuropsychological outcome six months after bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkison's disease (PD) patients and…
  • 2022 International Congress

    Investigating inflammatory mechanisms in iPSC-derived LRRK2 microglia

    K. Badanjak, P. Mulica, P. Seibler, M. Ali, C. Venegas, S. Pereira, C. Klein, P. Antony, E. Glaab, A. Grünewald (Esch-Sur-Alzette, Luxembourg)

    Objective: To characterize microglial function and inflammatory mechanisms in LRRK2-associated Parkinson’s disease (PD). Background: PD is a neurodegenerative disease affecting primarily dopaminergic neurons of the…
  • 2022 International Congress

    Genome-wide association study of Aβ, t-tau and p-tau in CSF in Parkinson’s disease

    H. Iwaki (Bethesda, USA)

    Objective: To investigate genetic contributions to the Alzheimer’s disease (AD) related cerebrospinal fluid (CSF) biomarkers in the patients with Parkinson’s disease (PD). Background: Aβ, t-tau…
  • 2022 International Congress

    An unusual cause of choreoathetosis: PRES and Goodpasture’s Syndrome

    M. Bonello, M. Cauchi, R. Debono, N. Vella (Pieta, Malta)

    Objective: Our aim is to shed light on an usual cause of choreoathetosis in a medically complex case. Background: Goodpasture’s syndrome(GBS) is a rare autoimmune…
  • 2022 International Congress

    Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease

    Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe (London, United Kingdom)

    Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease. Background: Neurological disorders frequently manifest…
  • 2022 International Congress

    Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Incremental Motor Improvement Observed with Increasing Doses

    S. Isaacson, I. Zhang, E. Pappert, A. Bowling (Boca Raton, USA)

    Objective: Evaluate magnitude of motor improvement with increasing doses of apomorphine sublingual film (SL-APO) in patients with Parkinson’s disease (PD) and OFF episodes. Background: Identifying…
  • 2022 International Congress

    Assessment of mood symptoms and influence on disease in cervical dystonia

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare mood symptom rating scales and influence of anxiety and depressive symptoms on motor severity and aspects of quality of life. Background: Cervical…
  • 2022 International Congress

    Asymmetry of Motor and Non-motor Signs in Parkinson’s Disease: An Exploratory Clinical Case-control Study

    F. Hansen, N. Okkels, P. Borghammer (Aarhus N, Denmark)

    Objective: To identify, quantify and correlate asymmetry between motor and non-motor signs in early Parkinson’s disease (PD). Background: Asymmetry of motor signs in PD reflects…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley